InsidersTradesSigma
Discover the complete record of transactions filed by Hirsch Andrew, Chairman & CEO. Officer active across 1 companies, notably C4 Therapeutics, Inc.. Cumulatively, 3 disclosures have been logged. Total volume traded: €78k. The latest transaction was disclosed on 26 May 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
3 of 3 declarations
Hirsch Andrew is the President and CEO of C4 Therapeutics, Inc., a biopharmaceutical company. He leads the company's operations and strategy, focusing on the development of innovative treatments for serious diseases.